Click on a filter below to refine your search. Remove a filter to broaden your search.
Hospitalization rates were 2.5 times higher for vaccinated patients without booster versus those with a booster.
Disparities were seen by geographic, sociodemographic and occupational subgroups.
An increased incidence of myocardial infarction and pulmonary embolism were seen in the second week after first dose of Oxford-AstraZeneca vaccine.
An efficacy of 92% was found among at-risk COVID-19-unvaccinated individuals with type 1 diabetes.
The updated vaccine is expected to have a “important role” in protecting people from COVID-19 this winter.
Under the law, Medicare will now be allowed to negotiate the cost of some drugs, and vaccines will be free for Part D recipients.
Substantial protection against hospitalizations and deaths seen among nursing home residents during the omicron surge.
Immunity resulting from previous COVID-19 infection and recent booster vaccination confers the strongest protection against the omicron infection.
Rates were slightly higher at 42 days for those receiving the Pfizer versus Moderna vaccine.
Those who are partially vaccinated and unvaccinated face the same increased risk, whereas boosted and fully vaccinated adults fare best.